HOPE GUERRERO: Open Payments
NPI 1841509114 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| BioMarin Pharmaceutical Inc. | 1 | $14 |
Products named: INTELLIS ADAPTIVESTIM, XIFAXAN, FARXIGA, BEXSERO, QULIPTA, VOXZOGO 1.2mg.
Industry payments across KS — which companies pay providers there.
